treatment

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder.

Rivera-Baltanas T, Olivares JM, Calado-Otero M, Kalynchuk LE, Martinez-Villamarin JR, Caruncho HJ. Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder. J Affect Disord. 2012;137(1-3):46-55. DOI: 10.1016/j.jad.2011.12.041. PubMed PMID: 22257570.

Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression.

Min J-A, Lee N-B, Lee C-U, Lee C, Chae J-H. Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression. J Affect Disord. 2012;137(1-3):61-9. DOI: 10.1016/j.jad.2011.12.026. PubMed PMID: 22244377.

Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program.

Stewart JG, Harkness KL. Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program. J Affect Disord. 2012;137(1-3):87-97. DOI: 10.1016/j.jad.2011.12.015. PubMed PMID: 22252094.

Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study.

Havnes I, Bukten A, Gossop M, Waal H, Stangeland P, Clausen T. Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study. Drug Alcohol Dependence. 2012;124(3):307-10. DOI: 10.1016/j.drugalcdep.2012.02.005. PubMed PMID: 22382045.

Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs).

Dennis ML, Scott CK. Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs). Drug Alcohol Dependence. 2012;121(1-2):10-7. DOI: 10.1016/j.drugalcdep.2011.07.026. PubMed PMID: 21903347; PubMed Central PMCID: PMC3277866.

Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings.

Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, et al. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Dependence. 2012;121(1-2):30-7. DOI: 10.1016/j.drugalcdep.2011.08.003. PubMed PMID: 21906892; PubMed Central PMCID: PMC3335347.

Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study.

Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophrenia Res. 2012;137(1-3):151-8. DOI: 10.1016/j.schres.2012.02.012. PubMed PMID: 22401837.

A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression.

Fitzgerald PB, Hoy KE, Herring SE, McQueen S, Peachey AVJ, Segrave RA, et al. A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. J Affect Disord. 2012;139(2):193-8. DOI: 10.1016/j.jad.2012.02.017. PubMed PMID: 22397890.

Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.

Wang M, Tong J-hua, Zhu G, Liang G-ming, Yan H-fei, Wang X-zhen. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. Schizophrenia Res. 2012;138(1):54-7. DOI: 10.1016/j.schres.2012.02.021. PubMed PMID: 22398127.

Opioid maintenance in European prisons: is the treatment gap closing?

Hedrich D, Farrell M. Opioid maintenance in European prisons: is the treatment gap closing?. Addiction. 2012;107(3):461-3. DOI: 10.1111/j.1360-0443.2011.03694.x. PubMed PMID: 22313099.